Modalis Therapeutics Corporation (4883.T)

JPY 75.0

(-1.32%)

Revenue Summary of Modalis Therapeutics Corporation

  • Modalis Therapeutics Corporation's latest annual revenue in 2023 was - JPY , down -100.0% from previous year.
  • Modalis Therapeutics Corporation's latest quarterly revenue in 2024 Q2 was - JPY , down 0.0% from previous quarter.
  • Modalis Therapeutics Corporation reported a annual revenue of 40.5 Million JPY in annual revenue 2022, up 3581.82% from previous year.
  • Modalis Therapeutics Corporation reported a annual revenue of 1.1 Million JPY in annual revenue 2021, down -99.68% from previous year.
  • Modalis Therapeutics Corporation reported a quarterly revenue of - JPY for 2024 Q2, down 0.0% from previous quarter.
  • Modalis Therapeutics Corporation reported a quarterly revenue of - JPY for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of Modalis Therapeutics Corporation (2023 - 2019)

Historical Annual Revenue of Modalis Therapeutics Corporation (2023 - 2019)

Year Revenue Revenue Growth
2023 - JPY -100.0%
2022 40.5 Million JPY 3581.82%
2021 1.1 Million JPY -99.68%
2020 342 Million JPY -46.89%
2019 644 Million JPY 0.0%

Peer Revenue Comparison of Modalis Therapeutics Corporation

Name Revenue Revenue Difference
Pharma Foods International Co., Ltd. 62.14 Billion JPY 100.0%
Takeda Pharmaceutical Company Limited 4263.76 Billion JPY 100.0%
Sumitomo Pharma Co., Ltd. 314.55 Billion JPY 100.0%
Shionogi & Co., Ltd. 435.08 Billion JPY 100.0%
Wakamoto Pharmaceutical Co.,Ltd. 7.73 Billion JPY 100.0%
Nippon Shinyaku Co., Ltd. 148.25 Billion JPY 100.0%
Kaken Pharmaceutical Co., Ltd. 72.04 Billion JPY 100.0%
Eisai Co., Ltd. 741.75 Billion JPY 100.0%
Morishita Jintan Co., Ltd. 12.4 Billion JPY 100.0%
Hisamitsu Pharmaceutical Co., Inc. 141.7 Billion JPY 100.0%
Mochida Pharmaceutical Co., Ltd. 102.88 Billion JPY 100.0%
Fuso Pharmaceutical Industries,Ltd. 55.4 Billion JPY 100.0%
Nippon Chemiphar Co., Ltd. 30.74 Billion JPY 100.0%
Tsumura & Co. 150.84 Billion JPY 100.0%
Kissei Pharmaceutical Co., Ltd. 75.57 Billion JPY 100.0%
Torii Pharmaceutical Co., Ltd. 54.63 Billion JPY 100.0%
Towa Pharmaceutical Co., Ltd. 227.93 Billion JPY 100.0%
Fuji Pharma Co., Ltd. 40.88 Billion JPY 100.0%
Zeria Pharmaceutical Co., Ltd. 75.72 Billion JPY 100.0%
KYORIN Holdings, Inc. 119.53 Billion JPY 100.0%
Taiko Pharmaceutical Co.,Ltd. 5.04 Billion JPY 100.0%
Daito Pharmaceutical Co.,Ltd. 46.89 Billion JPY 100.0%
SymBio Pharmaceuticals Limited 5.58 Billion JPY 100.0%
MedRx Co., Ltd 26 Million JPY 100.0%
Mizuho Medy Co.,Ltd. 10.98 Billion JPY 100.0%
Solasia Pharma K.K. 617 Million JPY 100.0%
ASKA Pharmaceutical Holdings Co.,Ltd. 62.84 Billion JPY 100.0%
Sawai Group Holdings Co., Ltd. 176.86 Billion JPY 100.0%
Cyfuse Biomedical K.K. 61.11 Million JPY 100.0%
Toho Holdings Co., Ltd. 1476.71 Billion JPY 100.0%
Koa Shoji Holdings Co.,Ltd. 22.13 Billion JPY 100.0%